Sign in
4

Changes in Ownership

Upstream Bio, Inc. Filed Acc 0000950170-24-114802

10% owner acquired 894,733 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner 2024-10-15 Conversion +894,733 894,733 D
Derivatives
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner 2024-10-15 Conversion · Series B redeemable convertible preferred stock −852,940 0 D
Loading xslF345X05/ownership.xml…